These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22002087)

  • 1. Cellular treatments for spinal cord injury: the time is right for clinical trials.
    Fehlings MG; Vawda R
    Neurotherapeutics; 2011 Oct; 8(4):704-20. PubMed ID: 22002087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives.
    Vawda R; Fehlings MG
    Curr Stem Cell Res Ther; 2013 Jan; 8(1):25-38. PubMed ID: 23270635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time is spine: a review of translational advances in spinal cord injury.
    Badhiwala JH; Ahuja CS; Fehlings MG
    J Neurosurg Spine; 2018 Dec; 30(1):1-18. PubMed ID: 30611186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?
    Kwon BK; Soril LJ; Bacon M; Beattie MS; Blesch A; Bresnahan JC; Bunge MB; Dunlop SA; Fehlings MG; Ferguson AR; Hill CE; Karimi-Abdolrezaee S; Lu P; McDonald JW; Müller HW; Oudega M; Rosenzweig ES; Reier PJ; Silver J; Sykova E; Xu XM; Guest JD; Tetzlaff W
    Exp Neurol; 2013 Oct; 248():30-44. PubMed ID: 23727091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cell transplantation a reliable therapeutic strategy for spinal cord injury in clinical practice? A systematic review and meta-analysis from 22 clinical controlled trials.
    Zhao H; Sun QL; Duan LJ; Yang YD; Gao YS; Zhao DY; Xiong Y; Wang HJ; Song JW; Yang KT; Wang XM; Yu X
    Eur Spine J; 2019 May; 28(5):1092-1112. PubMed ID: 30666481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-derived pluripotent stem cells.
    Faulkner SD; Vawda R; Fehlings MG
    World Neurosurg; 2014; 82(3-4):500-8. PubMed ID: 23948650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord injury and neural repair: focus on neuroregenerative approaches for spinal cord injury.
    Baptiste DC; Tighe A; Fehlings MG
    Expert Opin Investig Drugs; 2009 May; 18(5):663-73. PubMed ID: 19379122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.
    Illes J; Reimer JC; Kwon BK
    Stem Cell Rev Rep; 2011 Nov; 7(4):997-1005. PubMed ID: 21475955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell transplantation and clinical reality: Kuwait experience in persons with spinal cord injury.
    Al Kandari S; Prasad L; Al Kandari M; Ramachandran U; Krassioukov A
    Spinal Cord; 2018 Jul; 56(7):674-679. PubMed ID: 29472607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.
    Fawcett JW; Curt A; Steeves JD; Coleman WP; Tuszynski MH; Lammertse D; Bartlett PF; Blight AR; Dietz V; Ditunno J; Dobkin BH; Havton LA; Ellaway PH; Fehlings MG; Privat A; Grossman R; Guest JD; Kleitman N; Nakamura M; Gaviria M; Short D
    Spinal Cord; 2007 Mar; 45(3):190-205. PubMed ID: 17179973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From basics to clinical: a comprehensive review on spinal cord injury.
    Silva NA; Sousa N; Reis RL; Salgado AJ
    Prog Neurobiol; 2014 Mar; 114():25-57. PubMed ID: 24269804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement.
    Chhabra HS; Sarda K; Jotwani G; Gourie-Devi M; Kaptanoglu E; Charlifue S; Yadav SL; Mohapatra B; Srivastava A; Phadke K
    Eur Spine J; 2019 Aug; 28(8):1837-1845. PubMed ID: 31098715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.
    Saberi H; Moshayedi P; Aghayan HR; Arjmand B; Hosseini SK; Emami-Razavi SH; Rahimi-Movaghar V; Raza M; Firouzi M
    Neurosci Lett; 2008 Sep; 443(1):46-50. PubMed ID: 18662744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging characteristics of chronic spinal cord injury identified during screening for a cell transplantation clinical trial.
    Burks JD; Gant KL; Guest JD; Jamshidi AG; Cox EM; Anderson KD; Dietrich WD; Bunge MB; Green BA; Khan A; Pearse DD; Saraf-Lavi E; Levi AD
    Neurosurg Focus; 2019 Mar; 46(3):E8. PubMed ID: 30835682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regenerative rehabilitation with conductive biomaterials for spinal cord injury.
    Kiyotake EA; Martin MD; Detamore MS
    Acta Biomater; 2022 Feb; 139():43-64. PubMed ID: 33326879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury.
    Radtke C; Sasaki M; Lankford KL; Vogt PM; Kocsis JD
    J Rehabil Res Dev; 2008; 45(1):141-51. PubMed ID: 18566933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of trials for cell-based therapies in human spinal cord injury.
    Willison AG; Smith S; Davies BM; Kotter MRN; Barnett SC
    Spinal Cord; 2020 Aug; 58(8):844-856. PubMed ID: 32249830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury.
    Lepore AC
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of encapsulated autologous olfactory ensheathing cell populations expressing chondroitinase for spinal cord injury: A safety and feasibility study in companion dogs.
    Prager J; Fenn J; Plested M; Escauriaza L; Merwe TV; King B; Chari D; Wong LF; Granger N
    J Tissue Eng Regen Med; 2022 Sep; 16(9):788-798. PubMed ID: 35686704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.